With a key FDA decision on its non-nicotine therapy cytisinicline expected by mid-2026, Achieve Life Sciences (ACHV) is drawing bullish attention for its potential to address a massive unmet need in smoking cessation and tap into a newly opened market void.
The autonomous vehicle leader Waymo has closed a massive $16 billion funding round, catapulting its valuation to $126 billion. The capital infusion is set to turbocharge its international expansion plans, even as it navigates operational challenges and intensifying competition from rivals like Tesla and Amazon's Zoox.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
AbbVie's $2.1 billion acquisition of Capstan Therapeutics signals a strategic pivot towards next-generation immunology treatments. The move aims to secure future revenue streams as the company navigates the post-Humira era, with analysts highlighting the transformative potential of its in vivo CAR-T platform.
Exclusive BBC analysis reveals nearly half of accredited zoos and aquariums in the UK and Ireland have sounded financial alarms since 2022, forcing tough choices between conservation missions and economic reality.
Elon Musk consolidates his space and artificial intelligence ventures, with SpaceX acquiring xAI to form a private sector titan valued over a trillion dollars, aiming to solve AI's energy crisis by moving compute to space.
In an exclusive interview, GeneDx CEO Katherine Stueland details how rapid genomic testing is transforming pediatric care, slashing diagnosis times from years to days and building a data-driven bridge to future therapies.
Alphabet's autonomous vehicle unit Waymo is reportedly in talks to raise approximately $16 billion in a new financing round, which would value the company close to $110 billion. The move comes as the robotaxi pioneer faces heightened regulatory and public scrutiny following recent incidents involving its vehicles.
Elon Musk announces the merger of SpaceX and xAI, unveiling an ambitious plan to construct data centers in space, which he claims will become the most cost-effective source of AI computing power within years.
Palantir Technologies' stock gained momentum Monday following an upgrade by William Blair, a move vindicated after hours by a strong Q4 earnings report that exceeded forecasts and set robust guidance for 2026.
Shares of Huntington Bancshares (HBAN) have climbed over 17% in the past 90 days, closing recently at $17.88. This rally has investors scrutinizing whether the regional bank's stock still holds value after its strong run, with some models suggesting a significant upside to fair value.
A recent adjustment to Ceres Power Holdings' price target by analysts signals a broader reassessment of the clean energy firm's market narrative and future trajectory, moving beyond a single figure to underlying story shifts.
Merck & Co. is laying the groundwork for its future in oncology beyond Keytruda, announcing a strategic investment in biotech Eikon Therapeutics and a major collaboration with diagnostic leader Guardant Health. The moves signal a targeted, partnership-driven strategy to bolster its pipeline and diagnostics capabilities in the competitive cancer therapy market.
For the second consecutive year, a Chicago-based financial institution has become the nation's first bank to fail. Regulators shuttered Metropolitan Capital Bank & Trust on Friday, citing unsafe practices and depleted capital. The FDIC swiftly arranged for Detroit's First Independence Bank to assume most deposits and assets, ensuring customer funds remain secure.
Investment firm Hussman Strategic Advisors has liquidated its entire stake in TG Therapeutics, a move that comes as the biotech's stock lags behind broader market gains despite reporting strong revenue growth for its flagship product.
Natural gas futures tumbled over 25% on Monday, hitting a three-week low, as a swift recovery in U.S. production and a warmer weather forecast alleviated supply concerns sparked by last week's Arctic blast.
As Palantir Technologies reports a massive surge in U.S. government revenue, CEO Alex Karp publicly defends the company's controversial surveillance platforms, insisting they contain safeguards against overreach. The defense comes amidst growing public and political scrutiny over its contracts with immigration enforcement agencies.
Shares of the data analytics firm jumped more than 5% following a strong quarterly report that exceeded expectations and featured ambitious growth projections for the coming year.
The autonomous vehicle giant, backed by a consortium of major investors, plans to deploy its driverless fleet in over a dozen new international cities following a funding round that values the company at $126 billion.
Elon Musk has formally merged his rocket company SpaceX with artificial intelligence firm xAI, a strategic consolidation aimed at creating a vertically integrated powerhouse focused on AI and space infrastructure, according to an internal memo obtained by Business Insider.
